What is 3% w/v SODIUM CHLORIDE INTRAVENOUS INFUSION BP
3% w/v Sodium Chloride Intravenous Infusion BP is a sterile, hypertonic solution of sodium chloride designed for intravenous administration. It is primarily used for the treatment of severe hyponatremia (low serum sodium levels) and conditions requiring osmotic diuresis or intracranial pressure reduction.
- Composition: Each 100 mL contains 3 grams of sodium chloride (NaCl), equating to 513 mEq/L of sodium and chloride ions.
- Formulation: Clear, colorless solution in a 500 mL plastic bottle suitable for intravenous infusion.
- Pharmacological Category: Electrolyte replacement, osmotic agent.
- Indications:
- Treatment of symptomatic or severe hyponatremia
- Management of cerebral edema and increased intracranial pressure
- Adjunct in neurosurgical or neurocritical care scenarios
Due to its hypertonic nature, this solution is only administered in controlled clinical environments where electrolyte levels can be closely monitored.
How to use 3% w/v SODIUM CHLORIDE INTRAVENOUS INFUSION BP
This solution should be used only under the supervision of trained healthcare professionals with continuous monitoring of serum electrolytes and fluid balance.
- Route of Administration: Intravenous infusion, preferably through a central venous catheter due to hypertonicity.
- Infusion Rate:
- Typically initiated at a controlled rate of 1–2 mL/kg/hour
- Adjusted according to serum sodium levels, typically not exceeding 8–10 mEq/L correction in 24 hours
- Monitoring:
- Serum sodium every 2–4 hours during infusion
- Fluid intake/output, osmolality, and neurological status
- Precautions:
- Never administer rapidly unless in emergency
- Ensure product is clear and container integrity is intact
Administration should always be based on calculated sodium deficits and tailored to avoid complications like osmotic demyelination syndrome (ODS).
Mode of Action 3% w/v SODIUM CHLORIDE INTRAVENOUS INFUSION BP
3% Sodium Chloride exerts its therapeutic effect by replenishing deficient sodium ions and increasing extracellular osmolality, thereby promoting the movement of water from intracellular to extracellular compartments.
- Osmotic Effect: The hypertonic nature draws water out of swollen brain cells and other tissues, helping reduce cerebral edema.
- Electrolyte Restoration: Replenishes sodium levels in patients with symptomatic or severe hyponatremia.
- Volume Expansion: Temporarily expands plasma volume by shifting water into the intravascular space.
This solution does not provide calories or other electrolytes. Its effectiveness lies primarily in correcting sodium imbalances and managing fluid distribution in critical care scenarios.
3% w/v SODIUM CHLORIDE INTRAVENOUS INFUSION BP Interactions 3% w/v SODIUM CHLORIDE INTRAVENOUS INFUSION BP
This hypertonic sodium chloride solution may interact with other medications that influence fluid balance, electrolytes, or renal function. Understanding these interactions is essential for safe use.
- Diuretics (Loop or Thiazide):
- May enhance sodium depletion or cause unpredictable electrolyte shifts when used concurrently.
- Corticosteroids:
- Can increase sodium retention and fluid accumulation, raising the risk of hypertension or edema.
- Desmopressin (DDAVP):
- Used in hyponatremia management but may complicate correction if not properly timed or monitored.
- ACE Inhibitors/ARBs:
- May impact renal sodium handling and fluid excretion; requires close monitoring.
- Lithium:
- Sodium shifts may affect lithium excretion and increase risk of toxicity.
Always assess a patient’s complete medication list and adjust therapy accordingly under specialist supervision.
Dosage of 3% w/v SODIUM CHLORIDE INTRAVENOUS INFUSION BP
There is no fixed universal dose for 3% Sodium Chloride; dosage is individualized based on sodium deficit, patient weight, and clinical urgency.
- Initial Dosing: Typically 1–2 mL/kg/hour intravenously, though some cases may require bolus doses (e.g., 100–150 mL over 30–60 minutes in emergencies).
- Calculation: Sodium deficit (mEq) = (Desired Na⁺ – Current Na⁺) × TBW × 0.6 (adjusted by age/gender)
- Correction Target: Aim for a 4–6 mEq/L increase in the first 6 hours, but not more than 8–10 mEq/L in 24 hours.
- Maximum Daily Volume: Usually limited to avoid overcorrection, depending on fluid status and risk of demyelination.
Always tailor the dose to the patient’s clinical profile, lab data, and response to therapy. Continuous reevaluation is essential.
Possible side effects of 3% w/v SODIUM CHLORIDE INTRAVENOUS INFUSION BP
Like all hypertonic solutions, 3% Sodium Chloride may produce side effects if improperly administered or used without monitoring.
- Common Adverse Effects:
- Dry mouth or excessive thirst
- Headache or irritability
- Local vein irritation or phlebitis
- Serious Side Effects:
- Pulmonary edema
- Hypernatremia (serum sodium >145 mEq/L)
- Osmotic demyelination syndrome (ODS)
- Hypertension or cardiovascular strain
- Other Reactions:
- Electrolyte imbalance (e.g., hypokalemia)
- Seizures (from rapid correction of sodium)
Prompt recognition and intervention are essential in preventing permanent harm. Adverse effects should be reported and managed per hospital protocols.
3% w/v SODIUM CHLORIDE INTRAVENOUS INFUSION BP Contraindications 3% w/v SODIUM CHLORIDE INTRAVENOUS INFUSION BP
This solution is contraindicated in several clinical scenarios where sodium or fluid overload would pose a significant risk.
- Absolute Contraindications:
- Hypernatremia
- Severe congestive heart failure
- Anuria or severe renal failure not on dialysis
- Relative Contraindications:
- Uncontrolled hypertension
- Peripheral edema or ascites
- Preeclampsia or eclampsia
Careful clinical evaluation must precede administration. If contraindications exist, consider alternative treatment or lower concentration infusions under strict monitoring.
Storage of 3% w/v SODIUM CHLORIDE INTRAVENOUS INFUSION BP
To maintain product integrity and sterility, follow these guidelines for proper storage of this infusion solution.
- Temperature: Store at 20–25°C (68–77°F). Avoid excessive heat or freezing.
- Packaging: The solution is packaged in a plastic bottle that should remain sealed until use.
- Light Sensitivity: Not photosensitive but should be kept away from direct sunlight.
- Visual Check: Inspect before use for clarity, particulates, and seal integrity.
- Shelf Life: Use before expiration date on label; do not use if discolored or precipitated.
Ensure that storage areas are clean, dry, and designated for sterile IV fluids. Keep out of reach of unauthorized personnel or children.
3% w/v SODIUM CHLORIDE INTRAVENOUS INFUSION BP features an exceptional active ingredient renowned for its potent effects, comprising Sodium chloride. This powerful formulation provides a superior solution for addressing diverse health concerns. With 30mg/ml concentration and an easily manageable Infusion/Solution for, it remains a preferred option for countless individuals seeking effective treatment.
Introduction
All you need to know about 3% w/v SODIUM CHLORIDE INTRAVENOUS INFUSION BP .
Welcome to Dwaey, specifically on 3% w/v SODIUM CHLORIDE INTRAVENOUS INFUSION BP page.
This medicine contains an important and useful components, as it consists of Sodium chloride.
3% w/v SODIUM CHLORIDE INTRAVENOUS INFUSION BP is available in the market in concentration 30mg/ml and in the form of Infusion/Solution for.
QATAR PHARMA is the producer of 3% w/v SODIUM CHLORIDE INTRAVENOUS INFUSION BP and it is imported from QATAR,
The most popular alternatives of 3% w/v SODIUM CHLORIDE INTRAVENOUS INFUSION BP are listed downward .
-
Active Substance
-
Size
-
Indications
-
Type
-
Company
Frequently Asked Questions
3% w/v SODIUM CHLORIDE INTRAVENOUS INFUSION BP should be stored according to the instructions provided by QATAR PHARMA.
In general, it is recommended to store 3% w/v SODIUM CHLORIDE INTRAVENOUS INFUSION BP in a cool, dry place, away from direct sunlight
and out of the reach of children.
The duration of treatment with 3% w/v SODIUM CHLORIDE INTRAVENOUS INFUSION BP may vary depending on the condition being treated
and the guidance of your healthcare provider. It is important to follow the prescribed treatment
plan and continue taking 3% w/v SODIUM CHLORIDE INTRAVENOUS INFUSION BP for the recommended duration, even if your symptoms improve.
If you have any concerns or questions about the duration of treatment, consult your healthcare provider.
It is important to check with your healthcare provider or read the medication label for specific
instructions regarding alcohol consumption while taking 3% w/v SODIUM CHLORIDE INTRAVENOUS INFUSION BP. Some medications, including
3% w/v SODIUM CHLORIDE INTRAVENOUS INFUSION BP, may have interactions with alcohol that can reduce effectiveness, increase side
effects, or pose other risks to your health. It is best to follow the guidance provided by your
healthcare professional.
If you miss a dose of 3% w/v SODIUM CHLORIDE INTRAVENOUS INFUSION BP, take it as soon as you remember. However, if it is close
to the time for your next scheduled dose, skip the missed dose and continue with your regular dosing
schedule. Do not take a double dose to make up for a missed one unless advised by your healthcare provider.
No, do not stop taking 3% w/v SODIUM CHLORIDE INTRAVENOUS INFUSION BP without consulting your healthcare provider, even if your
symptoms improve. It is important to complete the full course of treatment as prescribed. Stopping
the medication prematurely may lead to a relapse or incomplete resolution of the condition. If you
have concerns about the duration of treatment, consult your healthcare provider for guidance.
It is important to consult your healthcare provider before taking 3% w/v SODIUM CHLORIDE INTRAVENOUS INFUSION BP if you are
pregnant or breastfeeding. They will be able to assess the potential risks and benefits based on your
specific situation. Please note that the safety and suitability of 3% w/v SODIUM CHLORIDE INTRAVENOUS INFUSION BP during pregnancy
or breastfeeding may depend on the active substance [Active Substance], concentration 30mg/ml,
and the specific recommendations of QATAR PHARMA.
The effects of 3% w/v SODIUM CHLORIDE INTRAVENOUS INFUSION BP on your ability to drive or operate machinery can vary depending on
the active substance [Active Substance], concentration 30mg/ml, and individual factors.
Some medications may cause drowsiness, dizziness, or other side effects that can impair your judgment
or coordination. It is important to read the medication label or consult your healthcare provider to
understand any potential effects on your ability to perform tasks that require alertness.
The instructions for taking 3% w/v SODIUM CHLORIDE INTRAVENOUS INFUSION BP with or without food may vary depending on the medication
and the recommendations of QATAR PHARMA. Some medications may be more effective when taken with
food to enhance absorption or reduce stomach irritation, while others may need to be taken on an empty
stomach for optimal absorption. Read the medication label or consult your healthcare provider for specific instructions.
The use of 3% w/v SODIUM CHLORIDE INTRAVENOUS INFUSION BP in children or elderly individuals may depend on various factors, including
the specific medication, type Infusion/Solution for, and the recommendations of QATAR PHARMA. Some
medications may have specific dosing instructions or precautions for these age groups. Consult your
healthcare provider or read the medication label for information regarding the safe and appropriate use
of 3% w/v SODIUM CHLORIDE INTRAVENOUS INFUSION BP in children or elderly individuals.
Dwaey
All medical information published on the Dwaey website aims to increase medical awareness and health education among users. However, it is not a substitute for professional medical advice. Always consult with a specialist doctor. We strongly advise against using any information or medicine found on the site without referring to your healthcare provider.
Related Products
0 Comments